Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 5Phase 2 3Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

INDIV 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Neoplasms 2Barrett Esophagus 1

Interventions

Proflavine 3Microbial Collagenase 2pegfilgrastim 1macimorelin 1Uracil 1Tegafur 1Sirolimus 1Mifepristone 1Gemcitabine 1Everolimus 1Darbepoetin alfa 1Corlux 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDIV × Proflavine × Clear all
NCT05396781 2022-06-09

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

Anandasabapathy, Sharmila, M.D.

Phase 2 Completed
41 enrolled
Tumor-Agnostic

Neoplasms

NCT02018367 2021-01-14

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
100 enrolled
Gastrointestinal

Barrett Esophagus

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
1,300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡